The Reinforcing Efficacy of the Dopamine Reuptake Inhibitor 2β-Propanoyl-3β-(4-tolyl)-tropane (PTT) as Measured by a Progressive-Ratio Schedule and a Choice Procedure in Rhesus Monkeys
- 1 January 2002
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 303 (2) , 640-648
- https://doi.org/10.1124/jpet.102.039180
Abstract
The present series of experiments was undertaken to investigate the variables that influence the reinforcing efficacy of psychostimulants. The time of onset for dopamine transporter (DAT) occupancy of the long-acting, high-affinity DAT blocker 2β-propanoyl-3β-(4-tolyl)-tropane (PTT) was measured using an ex vivo binding assay in rodents and was determined to be significantly longer than for cocaine (30 min versus 2 min). To assess the reinforcing efficacy of PTT relative to cocaine, a discrete-trials drug-drug choice procedure (n = 3) and a progressive-ratio (PR) schedule (n = 4) were used in rhesus monkeys. Cocaine (0.003–0.56 mg/kg/injection) and PTT (0.003–0.03 mg/kg/injection) maintained responding greater than saline under the PR schedule. Maximal breaking points were significantly higher for cocaine compared with PTT. A separate group of monkeys prepared with double-lumen catheters was allowed to choose between cocaine (saline and 0.03–0.3 mg/kg/injection) and PTT (saline, and 0.01 and 0.03 mg/kg/injection). Under these conditions, PTT was not preferred over saline. When saline or 0.01 mg/kg/injection PTT was available as alternatives to cocaine, the highest dose of cocaine maintained greater than 80% choice. When 0.03 mg/kg/injection PTT was the alternative to cocaine, cocaine choice declined to approximately 50%, and total cocaine intake was decreased by ∼70% at the highest cocaine dose. These results suggest that the reinforcing efficacy of PTT is less than cocaine in nonhuman primates. Data from studies with PTT indicate that slow-onset, long-acting DAT inhibitors can decrease cocaine self-administration while not functioning robustly as reinforcers, and support the further investigation of these drugs as treatment for cocaine addiction.This publication has 39 references indexed in Scilit:
- Sustained Decrease in Cocaine-Maintained Responding in Rhesus Monkeys with 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]- 4-(3-hydroxy-3-phenylpropyl)piperazinyl Decanoate, a Long-Acting Ester Derivative of GBR 12909Journal of Medicinal Chemistry, 1996
- Reinforcing and discriminative stimulus effects of β-CIT in rhesus monkeysPharmacology Biochemistry and Behavior, 1995
- The effects of delay of reinforcement and dose on the self-administration of cocaine and procaine in rhesus monkeysDrug and Alcohol Dependence, 1993
- Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatumEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Self-administration of the high-affinity cocaine analog 2β-carbomethoxy-3β-(4-fluorophenyl)tropanePharmacology Biochemistry and Behavior, 1991
- Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the ratLife Sciences, 1991
- Desipramine effects on cocaine self-administration by rhesus monkeysDrug and Alcohol Dependence, 1990
- Models of relative reinforcing efficacy of drugs and their predictive utilityBehavioural Pharmacology, 1990
- Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of CocaineScience, 1987
- Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeysPharmacology Biochemistry and Behavior, 1987